World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
70
Citations
16908
World Ranking
5870
National Ranking
126

Gianni Sava publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Gianni Sava sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 245 publications — 48th percentile

48% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Gianni Sava D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Gianni Sava sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 70 D-Index — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Gianni Sava is affiliated with the University of Trieste in Italy and has a research focus spanning medicine and biochemistry, genetics, and molecular biology. Their work covers several specialized subfields including surgery, hematology, endocrinology, molecular biology, and infectious diseases.

The scientist's recent publications highlight topics related to vaccination adverse events, muscle physiology, and antiviral natural products. Their work has appeared in multiple established journals, with some of the notable recent papers being:

  • "Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data" (2021), published in the Journal of Autoimmunity
  • "Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: An analysis of European data" (2021), published in the Journal of Autoimmunity
  • "Age Dependent Modification of the Metabolic Profile of the Tibialis Anterior Muscle Fibers in C57BL/6J Mice" (2020), published in the International Journal of Molecular Sciences
  • "Lysozyme: A Natural Product with Multiple and Useful Antiviral Properties" (2024), published in Molecules
  • "Long-term resveratrol treatment improves the capillarization in the skeletal muscles of ageing C57BL/6J mice" (2020), published in the International Journal of Food Sciences and Nutrition

Gianni Sava has contributed to studies frequently published in venues such as the Journal of Autoimmunity, Molecules, International Journal of Molecular Sciences, International Journal of Food Sciences and Nutrition, and Frontiers in Cardiovascular Medicine.

Their main research topics include heparin-induced thrombocytopenia and thrombosis, platelet disorders and treatments, Escherichia coli research studies, muscle physiology and disorders, adipose tissue and metabolism, aquaculture disease management and microbiota, and blood groups and transfusion.

Frequent collaborations feature co-authors such as Alberta Bergamo, Luigi Cari, Mahdieh Naghavi Alhosseini, Giuseppe Nocentini, and Emiliana Giacomello, indicating a consistent interdisciplinary approach across biomedical research areas.

Best Publications

  • In Vitro and in Vivo Evaluation of Ruthenium(II)−Arene PTA Complexes

    Claudine Scolaro;Alberta Bergamo;Laura Brescacin;Riccarda Delfino

  • Metal-based antitumour drugs in the post genomic era.

    Paul J Dyson;Gianni Sava

  • Approaching tumour therapy beyond platinum drugs : status of the art and perspectives of ruthenium drug candidates.

    A. Bergamo;C. Gaiddon;J.H.M. Schellens;J.H. Beijnen

  • Ruthenium Antimetastatic Agents

    Enzo Alessio;Giovanni Mestroni;Alberta Bergamo;Gianni Sava

  • A review on usnic acid, an interesting natural compound.

    Moreno Cocchietto;Nicola Skert;Pier Luigi Nimis;Gianni Sava

  • Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs.

    Alberta Bergamo;Gianni Sava

  • Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy

    Suzanne Leijen;Sjaak A. Burgers;Paul Baas;Dick Pluim

  • cis- and trans-dihalotetrakis(dimethyl sulfoxide)ruthenium(II) complexes (RuX2(DMSO)4; X=Cl, Br): synthesis, structure, and antitumor activity

    Enzo Alessio;Giovanni Mestroni;Giorgio Nardin;Wahib M. Attia

  • Organometallic ruthenium-based antitumor compounds with novel modes of action

    Wee Han Ang;Angela Casini;Gianni Sava;Paul J. Dyson

  • Dual Action of NAMI-A in Inhibition of Solid Tumor Metastasis Selective Targeting of Metastatic Cells and Binding to Collagen

    Gianni Sava;Sonia Zorzet;Claudia Turrin;Francesca Vita

  • Influence of chemical stability on the activity of the antimetastasis ruthenium compound NAMI-A

    G Sava;A Bergamo;S Zorzet;B Gava

  • Modulation of the metastatic progression of breast cancer with an organometallic ruthenium compound.

    Alberta Bergamo;Alessia Masi;Paul J Dyson;Gianni Sava

  • Metal-based antitumour drugs in the post-genomic era: what comes next?

    Gianni Sava;Alberta Bergamo;Paul J. Dyson

  • PHARMACOLOGICAL CONTROL OF LUNG METASTASES OF SOLID TUMOURS BY A NOVEL RUTHENIUM COMPLEX

    G. Sava;I. Capozzi;K. Clerici;G. Gagliardi

  • In vitro cell cycle arrest, in vivo action on solid metastasizing tumors, and host toxicity of the antimetastatic drug NAMI-A and cisplatin.

    A Bergamo;R Gagliardi;V Scarcia;A Furlani

  • Linking the future of anticancer metal-complexes to the therapy of tumour metastases

    Alberta Bergamo;Gianni Sava

  • Development of ruthenium antitumor drugs that overcome multidrug resistance mechanisms.

    Carsten A. Vock;Wee Han Ang;Claudine Scolaro;Andrew D. Phillips

  • The hydrolysis of the anti-cancer ruthenium complex NAMI-A affects its DNA binding and antimetastatic activity: an NMR evaluation.

    Marina Bacac;Anna C.G Hotze;Karlijn van der Schilden;Jaap G Haasnoot

  • In vivo tumour and metastasis reduction and in vitro effects on invasion assays of the ruthenium RM175 and osmium AFAP51 organometallics in the mammary cancer model

    A. Bergamo;A. Masi;Anna F. A. Peacock;Abraha Habtemariam

  • Water-Soluble Ruthenium(III)-Dimethyl Sulfoxide Complexes: Chemical Behaviour and Pharmaceutical Properties.

    G. Mestroni;E. Alessio;G. Sava;S. Pacor

  • Synthesis, catalytic properties and biological activity of new water soluble ruthenium cyclopentadienyl PTA complexes [(C5R5)RuCl(PTA)2] (R = H, Me; PTA = 1,3,5-triaza-7-phosphaadamantane).

    Dina N. Akbayeva;Luca Gonsalvi;Werner Oberhauser;Maurizio Peruzzini

Frequent Co-Authors

Enzo Alessio
Enzo Alessio University of Trieste
Giovanni Mestroni
Giovanni Mestroni University of Trieste
Paul J. Dyson
Paul J. Dyson École Polytechnique Fédérale de Lausanne
Jos H. Beijnen
Jos H. Beijnen Utrecht University
Bernhard K. Keppler
Bernhard K. Keppler University of Vienna
Ennio Zangrando
Ennio Zangrando University of Trieste
Maurizio Prato
Maurizio Prato University of Trieste
Luigi Messori
Luigi Messori University of Florence
Spiridione Garbisa
Spiridione Garbisa University of Padua
Jan H.M. Schellens
Jan H.M. Schellens Utrecht University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Chemistry in the USA opens doors to a variety of career paths, many of which can be enhanced through targeted online degrees. For those interested in legal support roles, pursuing a paralegal certificate can provide specialized knowledge and improve employability in law-related fields connected to chemical patenting or regulatory compliance.

Another promising avenue is the pharmaceutical industry. Breaking into sales roles is possible with a combination of scientific knowledge and business acumen. To learn how to position yourself for this, explore resources on how to get into pharmaceutical sales. This path leverages chemistry expertise to communicate product benefits effectively.

For those aiming to have a direct impact on patient health, becoming a pharmacist is a rewarding career choice. Understanding the steps to become a pharmacist is vital, including education, licensure, and practical experience requirements.

Finally, if you are fascinated by forensic and medical investigations, considering how an autopsy technician salary aligns with job outlooks might guide your decision. This career merges chemistry and biology to analyze causes of death and supports criminal justice.

Exploring these diverse pathways highlights the flexibility that a Chemistry background offers, especially when complemented by relevant certifications and industry knowledge.

Best Scientists Citing Gianni Sava

Trending Scientists

Recently Published Articles